Loading…

A clinical, molecular genetics and pathological study of a FTDP-17 family with a heterozygous splicing variant c.823-10G>T at the intron 9/exon 10 of the MAPT gene

•c.823-10G>T Microtubule associated tau (MAPT) gene variant was reported in one family with frontotemporal dementia.•No pathological data was available confirming the disease.•This is the first description of the pathology confirming that the variant is disease causing.•This is the first descript...

Full description

Saved in:
Bibliographic Details
Published in:Neurobiology of aging 2021-10, Vol.106, p.343.e1-343.e8
Main Authors: Olszewska, Diana A., Fearon, Conor, McGuigan, Christopher, McVeigh, Terri P, Houlden, Henry, Polke, James M, Lawlor, Brian, Coen, Robert, Hutchinson, Michael, Hutton, Michael, Beausang, Alan, Delon, Isabelle, Brett, Francesca, Sevastou, Ioanna, Seto-Salvia, Nuria, de Silva, Rohan, Lynch, Tim
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•c.823-10G>T Microtubule associated tau (MAPT) gene variant was reported in one family with frontotemporal dementia.•No pathological data was available confirming the disease.•This is the first description of the pathology confirming that the variant is disease causing.•This is the first description of the MND associated with c.823-10G>T MAPT variant. We report the first clinical-radiological-genetic-molecular-pathological study of a kindred with c.823-10G>T MAPT intronic variant (rs63749974) associated with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). We describe the clinical spectrum within this family and emphasize the association between MAPT gene variants and motor neuron disease. This report of a second family with FTDP-17 associated with c.823-10G>T MAPT variant strongly supports pathogenicity of the variant and confirms it is a 4-repeat (4R) tauopathy. This intronic point mutation, probably strengthens the polypyrimidine tract and alters the splicing of exon 10 (10 nucleotides into intron 9) close to the 3’ splice site.
ISSN:0197-4580
1558-1497
1558-1497
DOI:10.1016/j.neurobiolaging.2021.05.010